Winton Group’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Winton Group’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-46,087	Closed	-$6.28M	–	1609
2020 Q3	$6.28M	Buy	46,087 +25,353	+122%	+$2.7M	0.2%	70
2020 Q2	$2M	Buy	20,734 +7,374	+55%	+$615K	0.05%	653
2020 Q1	$626K	Sell	13,360 -42,196	-76%	-$2.7M	0.02%	967
2019 Q4	$4.05M	Buy	+55,556	New	+$3.37M	0.06%	548
2019 Q2	–	Sell	-5,061	Closed	-$263K	–	1341
2019 Q1	$263K	Sell	5,061 -2,807	-36%	-$129K	0.01%	846
2018 Q4	$384K	Sell	7,868 -1,436	-15%	-$79K	0.01%	567
2018 Q3	$607K	Sell	9,304 -2,319	-20%	-$136K	0.01%	554
2018 Q2	$577K	Sell	11,623 -2,320	-17%	-$112K	0.01%	602
2018 Q1	$680K	Buy	+13,943	New	+$725K	0.02%	643

Winton Group's MYOK Position: Q4 2020 in Review

Winton Group sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 46,087 shares — an estimated $6.28M sold.

Winton Group first reported a position in MYOK in Q1 2018 and held it in 9 quarters. The position peaked at $6.28M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

Winton Group reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Winton Group sold 46,087 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $6.28M.
Winton Group first reported a position in MyoKardia, Inc. Common Stock in Q1 2018 and held it in 9 quarters.
Winton Group's MyoKardia, Inc. Common Stock position peaked at $6.28M in Q3 2020.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Winton Group's 13F filing for Q4 2020, filed 12 Feb 2021.